🇸🇻

Pharmaceutical Products from El Salvador Tariff: 10% (2026)

Tariff Rate Breakdown

10%

Section 122 Base

10%

Effective Rate

CAFTA-DR — qualifying goods may enter duty-free

Importers sourcing pharmaceutical products from El Salvador face specific tariff considerations, with approximately $4B in total bilateral trade.

The current tariff framework for pharmaceutical products from El Salvador reflects the post-SCOTUS landscape: a 10% Section 122 tariff replaced the previously higher IEEPA rates after the Court's February 2026 ruling.

The Section 122 tariff is subject to a 150-day statutory time limit and is set to expire approximately July 24, 2026, unless Congress acts to extend or replace it. USTR has proposed 12.5% Section 301 duties on 46 countries — including China, Vietnam, India, Thailand, Japan, and South Korea — as a replacement, with a July 20, 2026 completion deadline, so importers should monitor developments closely as the deadline approaches.

Pharmaceutical Products (HTS Chapter 30) generally enter duty-free at the MFN level, with the Section 122 tariff as the primary duty. No additional Section 232 or Section 301 surcharges apply to most products in this category from El Salvador.

El Salvador is party to the CAFTA-DR, which may provide preferential or duty-free access for qualifying pharmaceutical products. Importers should verify rules of origin requirements to take advantage of preferential rates.

Key products in HTS Chapter 30 imported from El Salvador include Vaccines, Antibiotics, Insulin, Bandages, Diagnostic reagents, and Blood products.

Common Products in Chapter 30

VaccinesAntibioticsInsulinBandagesDiagnostic reagentsBlood productsPharmaceutical dosage formsFirst-aid kits

Calculate Your Import Duty

Use our tariff calculator to estimate the exact duty on your pharmaceutical products imports from El Salvador.

Open Tariff Calculator

Frequently Asked Questions

What is the current tariff rate on pharmaceutical products from El Salvador?

As of mid-2026, pharmaceutical products from El Salvador face a base tariff of 10% under Section 122. The effective rate is about 10% on the most-affected products.

Will the tariff on pharmaceutical products from El Salvador change?

The Section 122 tariff of 10% expires approximately July 24, 2026, unless Congress extends it — and USTR has proposed 12.5% Section 301 duties on 46 countries (including China, Vietnam, India, Thailand, Japan, and South Korea) as a replacement, with a July 20, 2026 completion deadline. Monitor developments for updates.

How did the Supreme Court ruling affect pharmaceutical products imports from El Salvador?

The Supreme Court's February 20, 2026 ruling struck down IEEPA reciprocal tariffs as exceeding presidential authority. The president signed a replacement 10% tariff under Section 122 the same day, effective February 24. Qualifying goods under CAFTA-DR may still enter duty-free.